Huawei banned from UK 5G network from 2021
The government has banned Chinese technology firm Huawei from providing telecommunications equipment to the UK’s mobile 5G network from the…
09 Jul 2020
Virtual trials: welcome to the present
By Alexander O'Leary It seems like for years the virtual clinical trial has been the future, and it is perhaps unsurprising that an industry that is famously quick to discuss…
24 Jun 2020
Alexander O’Leary Q&A: how are clinical trial sponsors’ outsourcing activities evolving?
The global clinical trial market is vast, but what are the major operational challenges that you have noticed many pharmaceutical and biotech companies choosing to outsource as opposed to managing…
18 Mar 2020
ZyVersa engages PPD for FSGS study, on crossover fundraising roadshow
ZyVersa Therapeutics has enlisted the CRO PPD to manage its upcoming Phase IIa focal segmental glomerulosclerosis (FSGS) study, said CEO Stephen Glover. The company is initiating a roadshow for crossover funding, with an…
28 Feb 2020
Overview of infectious disease clinical trials in China
The coronavirus outbreak, though the majority of cases have been in China, has affected many aspects of global life, especially businesses and travel. The virus can be easily spread from…
28 Feb 2020
vTv Therapeutics joins the oral drug market for type one diabetics
Earlier this month, vTv Therapeutics announced positive phase two results for its oral antidiabetic drug, TTP-399, when used as an adjunct therapy to insulin in type one diabetes (T1D) patients.…
20 Feb 2020
AI healthcare firm Viz.ai to expand clinical trial platform Viz RECRUIT
Applied artificial intelligence (AI) healthcare company Viz.ai has announced new algorithms and expanded features for its clinical trial platform, Viz RECRUIT. By employing AI, Viz RECRUIT will be able to…